(Q33742340)

29 July 2017

1 reference

title

Selective serotonin reuptake inhibitors and neuroendocrine function (English)

1 reference

29 July 2017

0 references

Raap DK

1

1 reference

29 July 2017

Van de Kar LD

series ordinal

2

1 reference

29 July 2017

language of work or name

English

0 references

publication date

1 January 1999

1 reference

29 July 2017

1 reference

29 July 2017

volume

65

1 reference

29 July 2017

issue

12

1 reference

29 July 2017

page(s)

1217-1235

1 reference

Fluoxetine and premature ejaculation: a double-blind, crossover, placebo-controlled study

29 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900169-1

Efficacy and safety of fluoxetine, sertraline and clomipramine in patients with premature ejaculation: a double-blind, placebo controlled study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900169-1

Serotonin function and antiaggressive response to fluoxetine: a pilot study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900169-1

Clinical improvement with fluoxetine therapy and noradrenergic function in patients with panic disorder

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900169-1

Mood disorders and menopause

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900169-1

Randomised, double-blind, placebo-controlled trial of pindolol in combination with fluoxetine antidepressant treatment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900169-1

A double-blind, placebo-controlled trial of the effect of fluoxetine on dietary intake in overweight women with and without binge-eating disorder

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900169-1

Long-term fluoxetine treatment of bulimia nervosa. Fluoxetine Bulimia Nervosa Research Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900169-1

Tryptophan depletion in patients with obsessive-compulsive disorder who respond to serotonin reuptake inhibitors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900169-1

Effect of a selective 5-HT reuptake inhibitor in combination with 5-HT1A and 5-HT1B receptor antagonists on extracellular 5-HT in rat frontal cortex in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900169-1

Role of 5-HT1A autoreceptors in the mechanism of action of serotoninergic antidepressant drugs: recent findings from in vivo microdialysis studies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900169-1

Raphe 5-HT1A autoreceptors, but not postsynaptic 5-HT1A receptors or beta-adrenoceptors, restrain the citalopram-induced increase in extracellular 5-hydroxytryptamine in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900169-1

Effects of acute and repeated administration of citalopram on extracellular levels of serotonin in rat brain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900169-1

Effect of chronic administration of the selective serotonin (5-HT) uptake inhibitor citalopram on extracellular 5-HT and apparent autoreceptor sensitivity in rat forebrain in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900169-1

Acceleration of the effect of selected antidepressant drugs in major depression by 5-HT1A antagonists.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900169-1

Can the effects of antidepressants be observed in the first two weeks of treatment?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900169-1

The suicide brain: a review of postmortem receptor/transporter binding studies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900169-1

Reduction by paroxetine of suicidal behavior in patients with repeated suicide attempts but not major depression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900169-1

Neurobiology of serotonin in depression and suicide

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900169-1

Abnormal 5-HT1D receptor function in major depression: a neuropharmacological challenge study using sumatriptan.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900169-1

Does central serotonergic function correlate inversely with aggression? A study using D-fenfluramine in healthy subjects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900169-1

Do noradrenergic reuptake inhibitors affect serotonergic function in depression?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900169-1

Effect of fluoxetine on noradrenergic mediated growth hormone release: A double blind, placebo-controlled study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900169-1

Long-term fluoxetine treatment decreases 5-HT1A receptor responsivity in obsessive-compulsive disorder

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900169-1

5-HT1A receptor responsivity in anxiety disorders and depression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900169-1

Plasma prolactin response to d-fenfluramine in obsessive-compulsive patients before and after fluvoxamine treatment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900169-1

Prolactin response to d-fenfluramine in obsessive-compulsive patients, and outcome of fluvoxamine treatment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900169-1

Cortisol response to d-fenfluramine in patients with obsessive-compulsive disorder and in healthy subjects: evidence for a gender-related effect.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900169-1

Neurocircuitry of stress: central control of the hypothalamo-pituitary-adrenocortical axis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900169-1

Forebrain pathways and their behavioural interactions with neuroendocrine and cardiovascular function in the rat.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900169-1

Forebrain pathways mediating stress-induced renin secretion.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900169-1

A prolactin-releasing peptide in the brain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900169-1

Effects of selective activation of dopamine D2 and D3 receptors on prolactin secretion and the activity of tuberoinfundibular dopamine neurons.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900169-1

Prolonged pertussis toxin treatment affects morphine's action on tuberoinfundibular dopaminergic neuron activity and on prolactin secretion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900169-1

Paraventricular nucleus controls 5-HT2C receptor-mediated corticosterone and prolactin but not oxytocin and penile erection responses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900169-1

Topography of serotonin neurons in the dorsal raphe nucleus that send axon collaterals to the rat prefrontal cortex and nucleus accumbens

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900169-1

Chemically defined collateral projections from the pons to the central nucleus of the amygdala and hypothalamic paraventricular nucleus in the rat

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900169-1

The hypothalamic paraventricular and lateral parabrachial nuclei receive collaterals from raphe nucleus neurons: a combined double retrograde and immunocytochemical study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900169-1

Synaptic interaction of serotonergic axons and corticotropin releasing factor (CRF) synthesizing neurons in the hypothalamic paraventricular nucleus of the rat. A light and electron microscopic immunocytochemical study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900169-1

The distribution and cells of origin of serotonergic inputs to the paraventricular and supraoptic nuclei of the rat

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900169-1

Differential serotonergic innervation of individual hypothalamic nuclei and other forebrain regions by the dorsal and median midbrain raphe nuclei

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900169-1

Effect of selective midbrain and diencephalic 5,7-dihydroxytryptamine lesions on serotonin content in individual preopticohypothalamic nuclei and on serum luteinizing hormone level

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900169-1

Physiopharmacological interactions between stress hormones and central serotonergic systems

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900169-1

Long-term fluoxetine, but not desipramine, inhibits the ACTH and oxytocin responses to the 5-HT1A agonist, 8-OH-DPAT, in male rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900169-1

Activation of 5-HT1A receptor subtype in the paraventricular nuclei of the hypothalamus induces CRH and ACTH release in the rat

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900169-1

5-Hydroxytryptamine1A receptor responsivity in obsessive-compulsive disorder. Comparison of patients and controls

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900169-1

Involvement of 5-HT2A receptors in the elevation of rat serum corticosterone concentrations by quipazine and MK-212

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900169-1

Stimulation of 5-HT1A and 5-HT2/5-HT1C receptors induce oxytocin release in the male rat.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900169-1

Effect of 5-HT1C and 5-HT2 receptor stimulation on excessive grooming, penile erection and plasma oxytocin concentrations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900169-1

Investigation of the role of 5-HT3 receptors in the secretion of prolactin, ACTH and renin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900169-1

Neuroendocrine responses to the serotonin2 agonist DOI are differentially modified by three 5-HT1A agonists

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900169-1

Effect of selective serotonin (5-HT) agonists and 5-HT2 antagonist on prolactin secretion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900169-1

Central administration of 5-HT activates 5-HT1A receptors to cause sympathoexcitation and 5-HT2/5-HT1C receptors to release vasopressin in anaesthetized rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900169-1

Neuropharmacological characterization of serotoninergic stimulation of vasopressin secretion in conscious rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900169-1

Endocrine responses to 5-hydroxytryptamine-1A receptor activation by ipsapirone in humans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900169-1

5-HT1A receptor sensitivity in major depression. A neuroendocrine study with buspirone

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900169-1

Monoaminergic regulation of neuroendocrine function and its modification by cocaine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900169-1

The effect of chronic fluvoxamine on hormonal and psychological responses to buspirone in normal volunteers.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900169-1

Serotonin1A receptor activation by flesinoxan in humans. Body temperature and neuroendocrine responses.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900169-1

Neuroendocrine effects of sumatriptan

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900169-1

Benzamide derivatives provide evidence for the involvement of a 5-HT4 receptor type in the mechanism of action of serotonin in frog adrenocortical cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900169-1

A serotonergic mechanism for the metoclopramide-induced increase in aldosterone level?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900169-1

Pharmacologic evidence for a serotonin neural pathway involved in hypothalamus-pituitary-adrenal function in rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900169-1

Fluoxetine reduces inflammatory edema in the rat: involvement of the pituitary-adrenal axis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900169-1

Serum corticosterone increases reflect enhanced uptake inhibitor-induced elevation of extracellular 5-hydroxytryptamine in rat hypothalamus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900169-1

Inhibition of GH in maternal separation may be mediated through altered serotonergic activity at 5-HT2A and 5-HT2C receptors.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900169-1

Serotonin indices and impulsivity in normal volunteers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900169-1

Neuroendocrine effects of a 20-mg citalopram infusion in healthy males. A placebo-controlled evaluation of citalopram as 5-HT function probe.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900169-1

Effect of sleep deprivation on neuroendocrine response to a serotonergic probe in healthy male subjects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900169-1

Neuroendocrine studies with fluvoxamine: animal data.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900169-1

The effect of a serotonin uptake inhibitor (Lilly 110140) on the secretion of prolactin in the rat

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900169-1

Further Evidence That Serotonin Is a Neurotransmitter Involved in the Control of Prolactin Secretion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900169-1

Evidence that serotonin neurons stimulate secretion of prolactin releasing factor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900169-1

Fluoxetine induces vasopressin and oxytocin abnormalities in food-restricted rats given voluntary exercise: relationship to anorexia nervosa

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900169-1

Effect of the serotonin reuptake inhibitor fluoxetine on corticotropin-releasing factor and vasopressin secretion into hypophysial portal blood

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900169-1

The effect of modulation of central serotonin neurotransmission on osmoregulated vasopressin release in rats.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900169-1

The effect of a highly specific serotonin agonist on osmoregulated vasopressin secretion in healthy man

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900169-1

Hormonal responses to d- and d,l-fenfluramine in healthy human subjects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900169-1

5-HT neuroendocrine function in major depression: prolactin and cortisol responses to D-fenfluramine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900169-1

The neuroendocrine response to d-fenfluramine in women with premenstrual depression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900169-1

Neuroendocrine evidence for an association between hypothyroidism, reduced central 5-HT activity and depression.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900169-1

Cortisol and prolactin responses to d-fenfluramine in non-depressed patients with obsessive-compulsive disorder: a comparison with depressed and healthy controls.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900169-1

The dexamethasone suppression test (DST) and platelet monoamine oxidase (MAO) activity as predictors of psychosis in depression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900169-1

Circadian rhythms and the pharmacology of affective illness

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900169-1

Oxytocin in the human--regulation of derivations and destinations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900169-1

The adrenal renin-angiotensin system: a local hormonal regulator of aldosterone production.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900169-1

Neuropeptides in anxiety disorders. Effects of lactation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900169-1

Neural mechanisms involved in the corticosteroid feedback effects on the hypothalamo-pituitary-adrenocortical axis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900169-1

Limbic pathways and hypothalamic neurotransmitters mediating adrenocortical responses to neural stimuli

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900169-1

Adrenergic control of the secretion of anterior pituitary hormones

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900169-1

Mechanisms of stress: a dynamic overview of hormonal and behavioral homeostasis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900169-1

Effect of pindolol on the L-5-HTP-induced increase in plasma prolactin and cortisol concentrations in man

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900169-1

Inhibitory effect of ritanserin on the 5-hydroxytryptophan-mediated cortisol, ACTH and prolactin secretion in humans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900169-1

The effect of IV L-tryptophan on prolactin, growth hormone, and mood in healthy subjects.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900169-1

Hormonal and behavioral effects associated with intravenous L-tryptophan administration.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900169-1

Do the endocrine and subjective effects of d-fenfluramine predict response to selective serotonin reuptake inhibitors?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900169-1

D-fenfluramine-induced prolactin and cortisol release in major depression: response to treatment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900169-1

Clinical studies of 5-HT function using i.v. L-tryptophan

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900169-1

Effects of desipramine and fluvoxamine treatment on the prolactin response to tryptophan. Serotonergic function and the mechanism of antidepressant action

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900169-1

Brain 5-HT neurotransmission during paroxetine treatment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900169-1

Fluoxetine, but not tricyclic antidepressants, potentiates the 5-hydroxytryptophan-mediated increase in plasma cortisol and prolactin secretion in subjects with major depression or with obsessive compulsive disorder.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900169-1

Corticosterone alters G protein α-subunit levels in the rat hippocampus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900169-1

Neuroendocrine effects of azapirones.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900169-1

5-HT1A receptor responsivity in unipolar depression. Evaluation of ipsapirone-induced ACTH and cortisol secretion in patients and controls.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900169-1

Effect of pindolol on endocrine and temperature responses to buspirone in healthy volunteers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900169-1

Effect of paroxetine and nefazodone on 5-HT 1A receptor sensitivity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900169-1

Effects of Divalproex Sodium on 5-HT1A Receptor Function in Healthy Human Males: Hypothermic, Hormonal, and Behavioral Responses to Ipsapirone

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900169-1

Blunted 5-HT1A-receptor agonist-induced corticotropin and cortisol responses after long-term ipsapirone and fluoxetine administration to healthy subjects.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900169-1

WAY-100635 inhibits 8-OH-DPAT-stimulated oxytocin, ACTH and corticosterone, but not prolactin secretion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900169-1

Neuroendocrine profile of the potential anxiolytic drug S-20499.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900169-1

A comparison of the oxytocin and vasopressin responses to the 5-HT1A agonist and potential anxiolytic drug alnespirone (S-20499).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900169-1

Activation of the 5-HT1A receptor subtype increases rat plasma ACTH concentration

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900169-1

Corticotropin and cortisol secretion after central 5-hydroxytryptamine-1A (5-HT1A) receptor activation: effects of 5-HT receptor and beta-adrenoceptor antagonists

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900169-1

Attenuation of hormone responses to the 5-HT1A agonist ipsapirone by long-term treatment with fluoxetine, but not desipramine, in male rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900169-1

Role of the hypothalamic paraventricular nucleus in 5-HT1A, 5-HT2A and 5-HT2C receptor-mediated oxytocin, prolactin and ACTH/corticosterone responses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900169-1

Effect of 8-hydroxy-2-(di-n-propylamino) tetralin on rat prolactin secretion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900169-1

Stimulation of serotonin1A receptors increases release of prolactin in the rat

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900169-1

Hypothalamic paraventricular nucleus lesions differentially affect serotonin-1A (5-HT1A) and 5-HT2 receptor agonist-induced oxytocin, prolactin, and corticosterone responses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900169-1

Central administration of 8-OH-DPAT and mCPP stimulates prolactin secretion in ovariectomized, estrogen-treated rats: lack of an effect on tuberoinfundibular dopaminergic neuron activity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900169-1

Flesinoxan pretreatment differentially affects corticosterone, prolactin and behavioural responses to a flesinoxan challenge

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900169-1

Changes in anterior pituitary hormone levels after serotonin 1A receptor stimulation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900169-1

Food intake, neuroendocrine and temperature effects of 8-OHDPAT in the rat.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900169-1

Influence of dose and route of administration on the kinetics of fluoxetine and its metabolite norfluoxetine in the rat

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900169-1

Pharmacokinetics of the newer antidepressants: clinical relevance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900169-1

Autoradiographic evidence for differential G-protein coupling of 5-HT1A receptors in rat brain: lack of effect of repeated injections of fluoxetine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900169-1

Early desensitization of somato-dendritic 5-HT1A autoreceptors in rats treated with fluoxetine or paroxetine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900169-1

Selective 5-HT1A and 5-HT2 receptor-mediated adrenocorticotropin release in the rat: effect of repeated antidepressant treatments

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900169-1

Pharmacological characterization of serotonin receptor subtypes involved in vasopressin and plasma renin activity responses to serotonin agonists

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900169-1

Effect of m-chlorophenylpiperazine on plasma arginine-vasopressin concentrations in healthy subjects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900169-1

Effect of cocaine injections on the neuroendocrine response to the serotonin agonist MK-212

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900169-1

Effect of serotonin on vasopressin release: a comparison to corticosterone, prolactin and renin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900169-1

Neuroendocrine and cardiovascular effects of serotonin: selective role of brain angiotensin on vasopressin.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900169-1

Neuroendocrine effects of quipazine in man in health state or with neurological disorders

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900169-1

Stimulation of serum cortisol and prolactin secretion in humans by MK-212, a centrally active serotonin agonist

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900169-1

Blunted oral body temperature response to MK-212 in cocaine addicts.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900169-1

Effect of pindolol pretreatment on MK-212-induced plasma cortisol and prolactin responses in normal men

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900169-1

Prolactin and cortisol responses to MK-212, a serotonin agonist, in obsessive-compulsive disorder.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900169-1

Acute intravenous administration of ondansetron and m-CPP, alone and in combination, in patients with obsessive-compulsive disorder (OCD): behavioral and biological results

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900169-1

Behavioral, physiological and neuroendocrine responses in healthy volunteers to m-chlorophenylpiperazine (m-CPP) with and without ondansetron pretreatment.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900169-1

Serotonin function in panic disorder: intravenous administration of meta-chlorophenylpiperazine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900169-1

Hormonal responses to the administration of m-chlorophenylpiperazine in patients with seasonal affective disorder and controls

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900169-1

Estrogen augments serotonergic activity in postmenopausal women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900169-1

Neuroendocrine probes of serotonergic function: a critical review

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900169-1

Effects of chronic fluoxetine treatment on behavioral and neuroendocrine responses to meta-chlorophenylpiperazine in obsessive-compulsive disorder

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900169-1

Neuroendocrine effects of M-chlorophenylpiperazine, a serotonin agonist, in humans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900169-1

Radiolabelling of the human 5-HT2A receptor with an agonist, a partial agonist and an antagonist: effects on apparent agonist affinities

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900169-1

SSRI treatment decreases prolactin and hyperthermic responses to mCPP.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900169-1

Frontal 5-HT2A receptors studied in depressive patients during chronic treatment by selective serotonin reuptake inhibitors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900169-1

Fluoxetine gradually increases [125I]DOI-labelled 5-HT2A/2C receptors in the hypothalamus without changing the levels of Gq- and G11-proteins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900169-1

Chronic citalopram and fluoxetine treatments upregulate 5-HT2c receptors in the rat choroid plexus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900169-1

Chronic fluoxetine or desmethylimipramine treatment alters 5-HT2 receptor mediated c-fos gene expression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900169-1

Effect of chronic administration of selective 5-hydroxytryptamine and noradrenaline uptake inhibitors on a putative index of 5-HT2C/2B receptor function

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900169-1

Evidence that chronic administration of paroxetine or fluoxetine enhances 5-HT2 receptor function in the brain of the guinea pig.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900169-1

Chronic fluoxetine treatment upregulates 5-HT uptake sites and 5-HT2 receptors in rat brain: an autoradiographic study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900169-1

Sumatriptan lowers plasma prolactin in healthy female volunteers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900169-1

Paroxetine treatment and the prolactin response to sumatriptan

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900169-1

The effects of sumatriptan on pituitary secretion in man.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900169-1

Attenuation of clonidine-induced growth hormone release following chronic glucocorticoid and 5-hydroxytryptamine uptake-inhibiting antidepressant treatments.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900169-1

Long-term antidepressant treatment restores clonidine's effect on growth hormone secretion in a genetic animal model of depression.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900169-1

Importance of duration of drug action in the antagonism of p-chloroamphetamine depletion of brain serotonin—comparison of fluoxetine and chlorimipramine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900169-1

Neuroendocrine response to clonidine and 8-OH-DPAT in rats following chronic administration of desipramine or sertraline

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900169-1

Persistence of blunted human growth hormone response to clonidine in fluoxetine-treated patients with panic disorder.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900169-1

Influence of serotonergic and adrenergic antagonists on TRH-induced prolactin release in the monkey

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900169-1

Evidence that thyrotropin-releasing hormone and a hypothalamic prolactin-releasing factor may function in the release of prolactin in the lactating rat

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900169-1

Neuroendocrine [corrected] regulation of prolactin release

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900169-1

Effects of vasoactive intestinal polypeptide, TRH, and dopamine on prolactin secretion in estrogen-primed postmenopausal women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900169-1

Effects of ECT course on TSH and prolactin responses of TRH in depressed patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900169-1

Decreased 5-HT-mediated prolactin release in major depression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900169-1

Dose-response studies with thyrotropin-releasing hormone: evidence for differential pituitary responses in men with major depression, alcoholism, or no psychopathology.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900169-1

Anger attacks in unipolar depression, Part 2: Neuroendocrine correlates and changes following fluoxetine treatment.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900169-1

TRH stimulation test as a predictor of acute and long-term antidepressant response in major depression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900169-1

Forebrain pathways mediating stress-induced hormone secretion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900169-1

Effects of the serotonin reuptake inhibitor fluvoxamine on yohimbine-induced anxiety in panic disorder.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900169-1

The antidepressants fluoxetine, idazoxan and phenelzine alter corticotropin-releasing hormone and tyrosine hydroxylase mRNA levels in rat brain: therapeutic implications

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900169-1

Plasma melatonin and cortisol circadian patterns in patients with obsessive-compulsive disorder before and after fluoxetine treatment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900169-1

Multiple hormone responses to stimulation with dl-fenfluramine in patients with major depression before and after antidepressive treatment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900169-1

Serotonin function in panic disorder: a double blind placebo controlled study with fluvoxamine and ritanserin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900169-1

Effect of Citalopram, a Selective 5-HT Reuptake Blocker, in Emotionally Disturbed Patients with Dementiaa

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900169-1

Vasopressin, oxytocin, corticotrophin-releasing factor, and sodium responses during fluoxetine administration in the rat.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900169-1

The effect of acute pharmacological manipulation of central serotonin neurotransmission on osmoregulated secretion of arginine vasopressin in the rat

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900169-1

Dexfenfluramine-induced prolactin release as an index of central synaptosomal 5-hydroxytryptamine during treatment with fluoxetine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900169-1

Changes in plasma prolactin during SSRI treatment: evidence for a delayed increase in 5-HT neurotransmission

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900169-1

Breast enlargement during chronic antidepressant therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900169-1

Lack of adverse interactions between concomitantly administered selegiline and citalopram

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900169-1

Sertraline treatment does not increase plasma prolactin levels in healthy subjects.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900169-1

Reduction of weight and left ventricular mass with serotonin uptake inhibition in obese patients with systemic hypertension

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900169-1

The reproducibility of the prolactin response to buspirone: relationship to the menstrual cycle

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900169-1

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0024-3205(99)00169-1

1 reference

29 July 2017

1 reference